Citicoline Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: phospholipid synthesis and cognitive function

Nootropic Compounds compound PowderCapsule needs_revision Best effort · source review pending

Also known as: CDP-Choline

Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes
1 g, 5 g, 10 g, 30 g, 250 mg capsules
Storage
Storage is form-specific; keep supplement powder dry and follow the supplier certificate for analytical citicoline sodium
Solubility
Citicoline sodium is water-soluble; a research supplier reports approximately 10 mg/mL in PBS at pH 7.2

Best-Effort Research Profile

Citicoline is cytidine diphosphate choline and is metabolized to choline and cytidine-related products after administration. Human research includes oral and parenteral formulations. A randomized trial in healthy older adults used 500 mg/day for 12 weeks; this does not establish a universal cognitive benefit or make retail supplements equivalent to drug formulations used outside the United States.

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Half-Life
Parent citicoline is rapidly metabolized and does not have one simple clinically transferable terminal half-life; older radiolabel studies describe multiphasic elimination
Onset
The healthy-older-adult trial assessed outcomes after 12 weeks; no validated immediate cognitive onset is established
Administration Routes (Research)
OralIntravenous (IV)

Reported Research Effects

Reported Research Side Effects

Data source: Randomized human trial plus current supplement and reagent catalogs

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Route-Specific Research Protocols

Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.

Label / guideline Human study Community only Preclinical only Not established
Oral Human study only

500 mg once daily

Frequency / timing
Daily
Duration / setting
12 weeks
Technique
Oral
Evidence
Human study protocol

Context: randomized placebo-controlled trial PMID 33978188

Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.

Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.

Intravenous (IV) Not established

No route-specific amount established in the reviewed record.

Technique
IV (some clinical stroke-treatment studies)
Evidence
Route noted; protocol not established

Context: The catalog identifies this route, but its reviewed sources do not establish a separate amount and schedule for it.

Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.

Route safety: No route-specific protocol is established. Do not infer an amount from another route, component, or formulation.

Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.

Research Notes

Current products include 250 mg capsules and 30 g powder; laboratory citicoline sodium is also sold in 1-10 g packs. Community reports of stimulation or insomnia are anecdotal.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources Under Review

Citicoline and Memory Function in Healthy Older Adults — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/33978188/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top